The historical rank and industry rank for Organigram Global's FCF Margin % or its related term are showing as below:
STU:0OG'
s FCF Margin % Range Over the Past 10 Years
Min: -1043.06 Med: -121.81 Max: -0.92
Current: -7.52
During the past 13 years, the highest FCF Margin % of Organigram Global was -0.92%. The lowest was -1043.06%. And the median was -121.81%.
STU:0OG's FCF Margin % is ranked worse than 70.46% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs STU:0OG: -7.52
Organigram Global FCF Margin % Related Terms
Organigram Global FCF Margin % Historical Data
* Premium members only.
The historical data trend for Organigram Global's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organigram Global FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Organigram Global's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Organigram Global's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organigram Global (STU:0OG) has a FCF Margin % of -11.72% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Organigram Global and its competitors. According to the industry distribution chart, Organigram Global ranks #675 out of 958 companies in the Drug Manufacturers industry, placing it in the top 70.5%.
Is Organigram Global's FCF Margin % too high?
Organigram Global's current FCF Margin % is -11.72%. Based on the distribution chart, Organigram Global ranks #675 out of 958 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Organigram Global has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organigram Global's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Organigram Global ranks #675 out of 958 companies for FCF Margin %. This places Organigram Global in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Organigram Global and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Organigram Global's current FCF Margin % is -11.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organigram Global stock overvalued right now?
Based on GuruFocus' analysis, Organigram Global (STU:0OG) is currently considered Possible Value Trap. The stock's GF Value™ is €1.46, compared to a current price of €0.82 — trading 44.1% below its estimated fair value. The current FCF Margin % is -11.72%. Organigram Global's overall GF Score™ is 60/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Organigram Global (STU:0OG), the current FCF Margin % is -11.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Organigram Global (STU:0OG) Overvalued in 2026?
Based on GuruFocus' analysis, Organigram Global stock appears to be undervalued.
The current stock price of €0.82 is trading 44.1% below its estimated GF Value™ of €1.46.
GuruFocus considers Organigram Global to be Possible Value Trap.
Key valuation signals for STU:0OG:
FCF Margin %: -11.72%
GF Value™: €1.46 vs. price of €0.82 (44.1% below fair value)
No single metric tells the full story. See the STU:0OG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
60GF Score
Get the complete analysis for STU:0OG
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:0OG has been successfully added to your 
